class action lawsuit semaglutide Ozempic makers face proposed over "dangerous side effects" Lawsuits claiming Ozempic, other GLP-1s

The phase 3b STEP UP obesity trial in more than 1,400 patients compared a 7.2mg weekly subcutaneous injection of semaglutide to the standard 2.6mg weekly dose sold as Wegovy or a matched placebo over 72 weeks

For many patients, glutathione is a core ingredient in beauty-focused IV therapy

PubMed Wadden, T.A., Chao, A.M., Machineni, S., Kushner, R.F., Ard, J., Srivastava, G., et al

Retatrutide still investigational may deliver deeper fat-mass reduction and a stronger metabolic shift, but with less long-term real-world data

Specifically, the group receiving retatrutide had significantly improved levels of kidney function parameters, as well as lower expression of inflammatory and fibrotic biomarkers in renal tissue